Related references
Note: Only part of the references are listed.Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q. M. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Joseph A. Califano et al.
CLINICAL CANCER RESEARCH (2015)
Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immunotherapy for head and neck squamous cell carcinoma
Qiao Li et al.
ORAL ONCOLOGY (2015)
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas
Edmund A. Mroz et al.
PLOS MEDICINE (2015)
Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
Yoshihiro Yoshitake et al.
CLINICAL CANCER RESEARCH (2015)
Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma
Ian-James Malm et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Head and neck cancer relapse after chemoradiotherapy correlates with CD163+macrophages in primary tumour and CD11b+myeloid cells in recurrences
P. Balermpas et al.
BRITISH JOURNAL OF CANCER (2014)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Patrick J. Schuler et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2014)
Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
H-B Jie et al.
BRITISH JOURNAL OF CANCER (2013)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Emily F. Stamell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma
Nadia Lago Costa et al.
ORAL ONCOLOGY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen
Neil L. Berinstein et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck
Anna-Maria A. De Costa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Cellular Constituents of Immune Escape within the Tumor Microenvironment
Sid P. Kerkar et al.
CANCER RESEARCH (2012)
inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma
Caroline J. Voskens et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer
Charles C. L. Tong et al.
IMMUNOLOGIC RESEARCH (2012)
Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance
Nobuyuki Fujii et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2012)
Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor-Targeted Therapy
Atul Bedi et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The clinical implications of antitumor immunity in head and neck cancer
Clint T. Allen et al.
LARYNGOSCOPE (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
NOVEL NEOADJUVANT IMMUNOTHERAPY REGIMEN SAFETY AND SURVIVAL IN HEAD AND NECK SQUAMOUS CELL CANCER
Gregory T. Wolf et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato et al.
IMMUNOLOGIC RESEARCH (2011)
Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma
Young-Ah Cho et al.
ORAL ONCOLOGY (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis
Nobuyuki Bandoh et al.
ONCOLOGY REPORTS (2010)
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
M. Czystowska et al.
CELL DEATH AND DIFFERENTIATION (2009)
Role of macrophages in tumour progression
K. S. Siveen et al.
IMMUNOLOGY LETTERS (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
Y. Mizukami et al.
BRITISH JOURNAL OF CANCER (2008)
Inhibitory B7-family molecules in the tumour microenvironment
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2008)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Increase in circulating Foxp3+CD4+CD25 high regulatory T cells in nasopharyngeal carcinoma patients
K-M Lau et al.
BRITISH JOURNAL OF CANCER (2007)
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker
Takeshi Ogino et al.
CANCER RESEARCH (2006)
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer
Robert L. Ferris et al.
CLINICAL CANCER RESEARCH (2006)
Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL
Andres Lopez-Albaitero et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Inhibition of NK cell activity through TGF-β1 by down-regulation of NKG2D in a murine model of head and neck cancer
S Dasgupta et al.
JOURNAL OF IMMUNOLOGY (2005)
Defects in the human leukocyte antigen class I antigen-processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome
M Meissner et al.
CLINICAL CANCER RESEARCH (2005)
Characteristics of CD4+ CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
C Schaefer et al.
BRITISH JOURNAL OF CANCER (2005)
Human leukocyte antigen (HLA) class I defects in head and neck cancer
RL Ferris et al.
IMMUNOLOGIC RESEARCH (2005)
Antigen-processing machinery in human dendritic cells: Up-regulation by maturation and down-regulation by tumor cells
TL Whiteside et al.
JOURNAL OF IMMUNOLOGY (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Assembly and export of MHC class I peptide ligands
AN Antoniou et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx
A De Stefani et al.
CANCER (2002)
Share Paper
